Filing Details
AVAI BIO, INC. (OTC:AVAI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
The Technology company reported Q0 revenue of .
10q filedOTC:AVAI
AVAI BIO, INC. (AVAI) Files Quarterly Report for Q0
AVAI BIO, INC. (OTC:AVAI) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
AVAI BIO, INC. (OTC:AVAI) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- AVAI BIO, INC. filed its quarterly report (Form 10-Q) with the SEC on August 13, 2026, providing unaudited financial statements and management commentary for Q0.
- The company's stock trades at $0.12 per share with a market capitalization of $43.5 million.
- As a technology company filing quarterly reports, AVAI BIO provides timely updates on emerging trends and risk factors, though the 10-Q contains less detail than the annual 10-K filing.
Market Context
AVAI BIO, INC.'s stock currently trades at $0.12 with a market capitalization of $43.5M.
The 10-Q provides AVAI BIO, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for AVAI BIO, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AVAI Stock Page
Frequently Asked Questions
Where can I read AVAI's SEC filings?
Browse all filings on our AVAI SEC filings page.
What types of SEC filings does AVAI BIO, INC. file?
Public companies like AVAI BIO, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
